Same-site transdifferentiation of basal cell carcinoma to squamous cell carcinoma as a mechanism of vismodegib treatment resistance: Two cases requiring multimodal and multidisciplinary limb-sparing techniques
Main Authors: | Brooke A. Burgess, MD, Rebecca J. Wang, BSA, Joshua L. Owen, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512623004538 |
Similar Items
-
Metastatic same-site squamous cell carcinoma arising during vismodegib therapy for basal cell carcinoma
by: Raymond Zhao, BS, et al.
Published: (2022-10-01) -
Successful treatment of squamous cell carcinoma with intralesional methotrexate
by: L.G. Vega-González, MD, et al.
Published: (2022-06-01) -
FR - Tratamiento intralesional del cáncer cutáneo no melanoma con 5-fluorouracilo
by: J. Gil-Lianes, et al.
Published: (2023-03-01) -
Clusterin modulates transdifferentiation of non-small-cell lung cancer
by: Runsen Jin, et al.
Published: (2017-09-01) -
Transformation of facial basal cell carcinoma to squamous cell carcinoma following vismodegib
by: Dustin A. Silverman, et al.
Published: (2021-09-01)